![]() |
市场调查报告书
商品编码
1383348
到 2030 年胶囊填充机的全球市场预测:按产品类型、容量类型、胶囊尺寸、剂量类型、材料、最终用户和地区进行的全球分析Capsule Filling Machines Market Forecasts to 2030 - Global Analysis By Product Type, Capacity Type, Capsule Size, Dosage Type, Material, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球胶囊填充机市场规模为 19.2 亿美元,预计预测期内年复合成长率为 8.7%,到 2030 年将达到 34.4 亿美元。
胶囊製造过程需要使用各种胶囊填充机来填充含有活性成分、其混合物和赋形剂组合的各种粉末和製剂,医生用这些机器来治疗各种疾病,向患者推荐这些胶囊。
根据美国商务部国际贸易管理局(ITA)的数据,美国是全球最大的医疗设备市场。 2017年美国整体估值为1,560亿美元,预计2023年将达2,080亿美元。
人口高龄化、医疗成本上升和新药开发等因素推动了製药业的强劲成长,推动了对大容量胶囊填充机的需求。此外,这些设备对于丸剂、颗粒剂、粉剂等各种剂型的生产至关重要,帮助製药公司有效满足消费者的需求。
儘管现代胶囊填充机具有多功能性,但有时可能难以适应新颖和不寻常的配方。有些配方可能需要专门的设备,特别是如果它们具有特殊的性质或输送机制。此外,对製造商来说,改造现有机械以适应新产品开发可能很困难。
随着仿製药产业的持续成长,蕴藏着巨大的机会。随着名牌药物的专利到期,对有效且负担得起的製造流程的需求增加。此外,胶囊填充机是仿製药生产的重要组成部分,使我们能够快速、经济地生产各种仿製药胶囊。
由于市场竞争激烈,製造商可能会捲入价格战。当价格主导的竞争降低报酬率时,投资于促进创新和产品差异化的研发计划就变得困难。製造商还需要在技术、客户服务和品牌方面跳出固有思维,才能在拥挤的市场中脱颖而出。
胶囊填充机市场受到 COVID-19大流行的多方面影响。疫情爆发初期,全球供应链和製造业务中断导致设备生产和分销延迟。此外,病毒传播的不确定性增加了对自动化和卫生胶囊填充机的需求。影响市场成长的负面因素包括财务困难、製药公司资本投资减少以及对非必要商业活动的法规。此外,对医疗保健的关注进一步凸显了复杂而有效的胶囊填充机对于製药和补充剂製造的重要性,而製药和营养补充食品仍然有能力抵消市场下滑的影响。仍然是服务于医疗保健的重要行业。
预计自动化部门的市场占有率最高。全自动胶囊充填机因其高速、高精度、高效率而成为营养补充和食品业的首选。这些设备可以准确快速地填充胶囊,最大限度地减少人为干预的需要并减少出错的可能性。此外,它在生产率、品管和成本效益方面具有优势,适合大规模生产。为了满足对胶囊不断增长的需求,同时保持稳定的产品品质并严格遵守法规标准,製药和营养补充食品经常采用自动化机械。
胶囊填充机市场预计将以生物公司领域最高的年复合成长率成长。开发和製造疫苗、生物製药和其他生技药品的生物技术相关企业需要更先进的胶囊填充机来封装精緻而有价值的材料。随着基因工程和生物技术的进步推动生物製药行业的成长,为满足生物产品独特需求而设计的专用胶囊填充机的需求预计将激增。此外,这些设备可确保生技药品的准确和无菌封装,使其成为相关企业生产过程中不可或缺的一部分。
包括美国和加拿大在内的北美地区预计将占据胶囊填充机市场的最大份额。这一优势得益于该地区完善的医疗保健和营养补充食品、严格的法规、高额的医疗保健支出以及对创新和产品品质的重视。北美的富裕程度允许采用胶囊填充机等尖端製造技术。此外,强大的製药管道和对研发的持续关注正在推动对这些设备的需求。
胶囊填充机市场预计将在亚太地区拥有最高的年复合成长率。多用户住宅和公共基础设施的发展、製药和营养补充食品的成长、都市化的加快以及中阶的壮大是支持这一强劲增长的一些因素。随着可支配所得的增加,亚太地区家庭对健康和保健的日益关注,推动了对药品、营养补充食品最终胶囊填充机的需求。此外,该地区不断提高的安全和法规标准也推动了先进胶囊製造技术的采用。
According to Stratistics MRC, the Global Capsule Filling Machines Market is accounted for $1.92 billion in 2023 and is expected to reach $3.44 billion by 2030 growing at a CAGR of 8.7% during the forecast period. The process of making capsules entails filling various powders or formulations containing active ingredients and their mixtures, as well as combinations of excipients, using a variety of capsule-filling machines, doctors recommend these capsules to their patients in order to treat a range of illnesses.
According to the International Trade Administration (ITA), the US Department of Commerce is the world's largest market for medical devices. Its overall valuation was US$ 156 billion in 2017, which is expected to reach US$ 208 billion by 2023.
The need for high-capacity capsule filling machines stems from the pharmaceutical industry's strong growth, which is fueled by factors like aging populations, rising healthcare costs, and the development of new medications. Moreover, these devices are essential to the production of different drug formulations, such as pellets, granules, and powders, which help pharmaceutical companies effectively, meet consumer demand.
Despite their versatility, contemporary capsule filling machines may have issues handling novel and unusual drug formulations. Some formulations may require specialized equipment, especially if they have special characteristics or delivery mechanisms. Additionally, this can make it challenging for manufacturers to modify their current machinery to accommodate the development of new products.
There is a big opportunity due to the generic pharmaceutical industry's continued growth. Demand for effective and affordable manufacturing processes is rising as more patents for name-brand medications expire. Furthermore, the ability of manufacturers to swiftly and affordably produce a large variety of generic capsules is made possible by capsule filling machines, which can be crucial in the production of generic drugs.
Manufacturers may engage in price wars as a result of the fierce market competition. It can be difficult for businesses to invest in R&D projects that could spur innovation and product differentiation when price-driven competition erodes profit margins. Moreover, manufacturers need to think outside the box when it comes to technology, customer service, and branding in order to stand out in a crowded market.
The market for capsule filling machines was impacted in a number of ways by the COVID-19 pandemic. Early in the pandemic, delays in equipment production and distribution were caused by disruptions in global supply chains and manufacturing operations. There was also a rise in demand for automated and sanitary capsule filling machines due to the uncertainty surrounding the virus's spread. Negative factors affecting market growth included financial difficulties, pharmaceutical companies cutting back on capital expenditures, and regulations on non-essential business operations. Additionally, the focus on healthcare further highlighted the significance of sophisticated and effective capsule filling machines for medicine and supplement production, but the pharmaceutical and nutraceutical sectors continued to be vital industries that helped offset the market's fall.
It is projected that the automatic segment will have the largest market share. For their high speed, accuracy, and efficiency, automatic capsule filling machines are preferred in the nutraceutical and pharmaceutical industries. These devices can fill capsules precisely and swiftly, minimizing the need for human intervention and lowering the possibility of mistakes. Moreover, they are advantageous in terms of productivity, quality control, and cost-effectiveness and are appropriate for large-scale production. For the purpose of satisfying the increasing demand for capsules while maintaining consistent product quality and strict adherence to regulatory standards, pharmaceutical and nutraceutical manufacturers frequently favor automatic machines.
The market for capsule filling machines is expected to grow at the highest CAGR in the biological company segment. Biological companies that develop and produce vaccines, biopharmaceuticals, and other biologics need more sophisticated capsule filling machines to encapsulate sensitive and valuable materials. With advances in genetic engineering and biotechnology propelling the biopharmaceutical industry's growth, demand for specialized capsule filling machines designed to meet the specific needs of biological products is anticipated to soar. Additionally, these devices are a vital part of biological companies' production processes because they guarantee the accurate and sterile encapsulation of biologics.
It is projected that in the capsule filling machine market, the North American region, which includes the United States and Canada, will hold the largest share. This dominance is ascribed to the region's well-established healthcare and nutraceutical industries, strict regulations, high spending on healthcare, and a strong emphasis on innovation and product quality. The wealth of North America makes it possible for cutting-edge manufacturing technologies, such as capsule filling machines, to be adopted. Furthermore, a robust pharmaceutical pipeline and an ongoing focus on research and development fuel demand for these devices.
In the market for capsule filling machines, the Asia-Pacific region is projected to have the highest CAGR. The development of multi-story housing and public infrastructure, the growth of the pharmaceutical and nutraceutical industries, rising urbanization, and the middle class are some of the factors driving this robust growth. The demand for pharmaceuticals, dietary supplements, and, eventually, capsule filling machines is driven by the growing emphasis on health and wellness among families in the Asia-Pacific region as disposable incomes rise. Additionally, the adoption of advanced technologies for capsule production is being encouraged by the region's heightened safety and regulatory standards.
Some of the key players in Capsule Filling Machines market include: Kambert Machinery Co. Pvt. Ltd., Hanlin Hangyu Industrial Co., Ltd., Capsugel, Inc, Dott Bonapace & C Srl, ACIC Pharmaceutical Machinery, Harro Hofliger Verpackungsmaschinen GmbH, Torpac Inc. , Jornen Machinery Co., Ltd., Qualicaps Co., Ltd., Robert Bosch GmbH, IMA Industria Macchine Automatiche SpA, Zhejiang Fuchang Machinery, N.K Industries , SaintyCo International Group, Shanghai Jiuwu Pharmtech Machinery Co. Ltd., Titan Pharmaceutical Machinery, ACG Pam Pharma Technologies Private Limited , Romaco Group, M2G S.r.l, Schaefer Technologies Inc and Adinath International.
In July 2023, Qualicaps acquired by Roquette. Roquette, a global leader in plant-based ingredients and pharmaceutical excipients, announced today an agreement to acquire Qualicaps and reinforce its position as a major supplier to the pharmaceutical industry. The combination of the two businesses will contribute to Roquette's strategic growth plan and will create new opportunities for Roquette and Qualicaps' customers and employees.
In April 2022, Harro Hofliger will take over the business operations of Widmann Maschinen GmbH & Co. KG in Schlierbach and thus invest in the growth market of pharmaceuticals and medical technology. Widmann Maschinen, founded in Esslingen in 1946, develops, builds and maintains series and special machines that are used for packaging food and cosmetics, in the automotive industry and medical technology. The family business specializes in manufacturing of film processing and bag filling systems as well as the ultrasonic welding of film materials.
In February 2022, Titan International, Inc. and Kubota Tractor Corporation (KTC) / Kubota Canada Limited (KCL) have entered into an exclusivity agreement on select sizes of Titan's new Trac Loader II tires for compact and utility tractor models used in residential, commercial, agricultural, and light construction applications. This innovative tire, branded with Titan and Kubota both displayed on the sidewall of the tire, will bring new value to Titan and Kubota customers.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.